SCHEMBL3131588

SCHEMBL3131588

CCN1C(=O)C(=Cc2ccc(-c3cccc(Cl)c3)o2)SC1=S

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.77
▸ MAP3K5 Q99683 3/20 0.74
▸ DUSP3 P51452 1/20 0.74
▸ STAT3 P40763 1/20 0.64
▸ POLB P06746 5/20 0.61
▸ MEN1 O00255 4/20 0.61
▸ KMT2A Q03164 4/20 0.61
▸ PLA2G1B P04054 1/20 0.61
▸ BLM P54132 1/20 0.61
▸ GFER P55789 1/20 0.61
▸ ATG4B Q9Y4P1 1/20 0.61
▸ APEX1 P27695 1/20 0.60
▸ TNFRSF1A P19438 1/20 0.59
▸ ALDH1A1 P00352 4/20 0.57
▸ TDP1 Q9NUW8 2/20 0.57
▸ HPGD P15428 1/20 0.57
▸ HIF1AN Q9NWT6 1/20 0.56
▸ EIF4E P06730 1/20 0.56
▸ EIF4G1 Q04637 1/20 0.56
▸ THRB P10828 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3129308 1.00 MAPT (0.77) MAPTMAP3K5DUSP3STAT3POLB
SCHEMBL3131581 1.00 MAPT (0.77) MAPTMAP3K5DUSP3STAT3POLB
SCHEMBL3890828 0.88 MAPT (0.74) MAPTMAP3K5DUSP3POLBMEN1
SCHEMBL3890825 0.88 MAPT (0.74) MAPTMAP3K5DUSP3POLBMEN1
SCHEMBL3122820 0.88 STAT3 (0.64) MAPTMAP3K5DUSP3STAT3POLB
SCHEMBL3122808 0.88 STAT3 (0.64) MAPTMAP3K5DUSP3STAT3POLB
SCHEMBL3122825 0.88 STAT3 (0.64) MAPTMAP3K5DUSP3STAT3POLB
SCHEMBL3894481 0.87 MAPT (1.00) MAPTMAP3K5DUSP3POLBMEN1
SCHEMBL3894483 0.87 MAPT (1.00) MAPTMAP3K5DUSP3POLBMEN1
SCHEMBL3131544 0.87 STAT3 (0.78) MAPTMAP3K5STAT3POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-08-30 — — US claimed
WO-2010044924-A1 NOVEL ANTIVIRAL AGENTS FOR ENVELOPED VIRUSES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-04-22 — — WO claimed
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-08-30 — — US disclosed
WO-2010044924-A1 NOVEL ANTIVIRAL AGENTS FOR ENVELOPED VIRUSES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-04-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120219613-A1 Novel Antiviral Agents for Enveloped Viruses MAVS, LAMP1, HAVCR2 MAPT 3126/4885MAP3K5 3869/4885DUSP3 3629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback